Skip NavigationSkip to Content

Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10

  1. Author:
    Buel,Gwen [ORCID]
    Chen,Xiang [ORCID]
    Chari,Raj
    O'Neill, Maura J
    Ebelle, Danielle L
    Jenkins, Conor
    Sridharan, Vinidhra
    Tarasov,Sergey
    Tarasova,Nadya
    Andresson,Thorkell
    Walters,Kylie
  2. Author Address

    Protein Processing Section, Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA., Protein Processing Section, Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA. xiang.chen@nih.gov., Genome Modification Core, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA., Protein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA., Biophysics Resource, Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA., Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA., Protein Processing Section, Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA. kylie.walters@nih.gov.,
    1. Year: 2020
    2. Date: Mar 10
    3. Epub Date: 2020 03 10
  1. Journal: Nature communications
    1. 11
    2. 1
    3. Pages: 1291
  2. Type of Article: Article
  3. Article Number: 1291
  4. ISSN: 2041-1723
  1. Abstract:

    Regulated proteolysis by proteasomes involves ~800 enzymes for substrate modification with ubiquitin, including ~600 E3 ligases. We report here that E6AP/UBE3A is distinguished from other E3 ligases by having a 12?nM binding site at the proteasome contributed by substrate receptor hRpn10/PSMD4/S5a. Intrinsically disordered by itself, and previously uncharacterized, the E6AP-binding domain in hRpn10 locks into a well-defined helical structure to form an intermolecular 4-helix bundle with the E6AP AZUL, which is unique to this E3. We thus name the hRpn10 AZUL-binding domain RAZUL. We further find in human cells that loss of RAZUL by CRISPR-based gene editing leads to loss of E6AP at proteasomes. Moreover, proteasome-associated ubiquitin is reduced following E6AP knockdown or displacement from proteasomes, suggesting that E6AP ubiquitinates substrates at or for the proteasome. Altogether, our findings indicate E6AP to be a privileged E3 for the proteasome, with a dedicated, high affinity binding site contributed by hRpn10.

    See More

External Sources

  1. DOI: 10.1038/s41467-020-15073-7
  2. PMID: 32157086
  3. PMCID: PMC7064531
  4. WOS: 000549170700003
  5. PII : 10.1038/s41467-020-15073-7

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel